Skin Distress Screening: Validation of an Efficient One-question Tool
DOI:
https://doi.org/10.2340/actadv.v103.4590Keywords:
distress thermometer, health-related quality of life, skin diseases, validation study, depression, anxietyAbstract
Skin diseases are often accompanied by physical, emotional and social problems, which may negatively impact health-related quality of life and result in skin-related distress. It is essential to identify patients with skin-related distress within the short time-window of an outpatient dermatological visit. Therefore the one-question screening tool, the Distress Thermometer adjusted for skin conditions, was validated in a cross-sectional questionnaire study. In 2 medical centres in Amsterdam, 214 patients with a chronic skin disease were invited to complete the Distress Thermometer and additional health-related quality of life questionnaires. To validate the Distress Thermometer, the Skindex29 was used as gold standard. To test test–retest reliability, the questionnaires were answered at 2 different time-points. Severely impaired health-related quality of life was present in 30% of respondents according to the Skindex29 using a cut-off score of 44. Receiver operating characteristic curve analyses yielded an area under the curve of 0.813 (standard error 0.04, 95% confidence interval 0.74–0.89). A cut-off score ≥ 4 on the Distress Thermometer provided the optimal ratio of sensitivity (90.7%) to specificity (56.1%). Therefore, for general practice, a cut-off score of ≥ 4 on the Distress Thermometer is advised. The Distress Thermometer seems to be a rapid, valid and reliable screening tool for identifying skin-related distress in patients with a chronic skin disease in the outpatient dermatology setting.
Downloads
References
Hay RJ, Johns NE, Williams HC, Bolliger IW, Dellavalle RP, Margolis DJ, et al. The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions. J Invest Dermatol 2014; 134: 1527-1534.
https://doi.org/10.1038/jid.2013.446 DOI: https://doi.org/10.1038/jid.2013.446
Karimkhani C, Dellavalle RP, Coffeng LE, Flohr C, Hay RJ, Langan SM, et al. Global skin disease morbidity and mortality: an update from the Global Burden of Disease Study 2013. JAMA Dermatol 2017; 153: 406-412.
https://doi.org/10.1001/jamadermatol.2016.5538 DOI: https://doi.org/10.1001/jamadermatol.2016.5538
Evers AW, Crijns MB, Kemperman PM. [A peek inside the field of psychodermatology]. Ned Tijdschr Geneeskd 2013; 157: A5659 (in Dutch).
Evers AW, Duller P, van de Kerkhof PC, van der Valk PG, de Jong EM, Gerritsen MJ, et al. The Impact of Chronic Skin Disease on Daily Life (ISDL): a generic and dermatology-specific health instrument. Br J Dermatol 2008; 158: 101-108.
Jafferany M, Pastolero P. Psychiatric and psychological impact of chronic skin disease. Prim Care Companion CNS Disord 2018; 20: 17nr02247.
https://doi.org/10.4088/PCC.17nr02247 DOI: https://doi.org/10.4088/PCC.17nr02247
Evers AW, Verhoeven EW, Kraaimaat FW, de Jong EM, de Brouwer SJ, Schalkwijk J, et al. How stress gets under the skin: cortisol and stress reactivity in psoriasis. Br J Dermatol 2010; 163: 986-991.
https://doi.org/10.1111/j.1365-2133.2010.09984.x DOI: https://doi.org/10.1111/j.1365-2133.2010.09984.x
Hunter HJ, Momen SE, Kleyn CE. The impact of psychosocial stress on healthy skin. Clin Exp Dermatol 2015; 40: 540-546.
https://doi.org/10.1111/ced.12582 DOI: https://doi.org/10.1111/ced.12582
Rodriguez-Vallecillo E, Woodbury-Farina MA. Dermatological manifestations of stress in normal and psychiatric populations. Psychiatr Clin North Am 2014; 37: 625-651.
https://doi.org/10.1016/j.psc.2014.08.009 DOI: https://doi.org/10.1016/j.psc.2014.08.009
Fortune DG, Richards HL, Kirby B, McElhone K, Markham T, Rogers S, et al. Psychological distress impairs clearance of psoriasis in patients treated with photochemotherapy. Arch Dermatol 2003; 139: 752-756.
https://doi.org/10.1001/archderm.139.6.752 DOI: https://doi.org/10.1001/archderm.139.6.752
Renzi C, Abeni D, Picardi A, Agostini E, Melchi CF, Pasquini P, et al. Factors associated with patient satisfaction with care among dermatological outpatients. Br J Dermatol 2001; 145: 617-623.
https://doi.org/10.1046/j.1365-2133.2001.04445.x DOI: https://doi.org/10.1046/j.1365-2133.2001.04445.x
Renzi C, Picardi A, Abeni D, Agostini E, Baliva G, Pasquini P, et al. Association of dissatisfaction with care and psychiatric morbidity with poor treatment compliance. Arch Dermatol 2002; 138: 337-342.
https://doi.org/10.1001/archderm.138.3.337 DOI: https://doi.org/10.1001/archderm.138.3.337
Koulil S, Waalboer-Spuij R, Boonstra HE, Casteelen G, Evers AWM, Korte J, et al. [Psychodermatology in research and practice: Developments in academic centers in the Netherlands]. Nederlands Tijdschrift voor Dermatologie en Venereologie 2013; 23: 583-589 (in Dutch).
David SE, Ahmed Z, Salek MS, Finlay AY. Does enough quality of life-related discussion occur during dermatology outpatient consultations? Br J Dermatol 2005; 153: 997-1000.
https://doi.org/10.1111/j.1365-2133.2005.06876.x DOI: https://doi.org/10.1111/j.1365-2133.2005.06876.x
Hermansen SE, Helland CA, Finlay AY. Patients' and doctors' assessment of skin disease handicap. Clin Exp Dermatol 2002; 27: 249-250.
https://doi.org/10.1046/j.1365-2230.2002.10263.x DOI: https://doi.org/10.1046/j.1365-2230.2002.10263.x
Picardi A, Amerio P, Baliva G, Barbieri C, Teofoli P, Bolli S, et al. Recognition of depressive and anxiety disorders in dermatological outpatients. Acta Derm Venereol 2004; 84: 213-217.
https://doi.org/10.1080/00015550410025264 DOI: https://doi.org/10.1080/00015550410025264
Silverberg JI. Comorbidities and the impact of atopic dermatitis. Ann Allergy Asthma Immunol 2019; 123: 144-151.
https://doi.org/10.1016/j.anai.2019.04.020 DOI: https://doi.org/10.1016/j.anai.2019.04.020
Carlson LE, Bultz BD. Cancer distress screening. Needs, models, and methods. J Psychosom Res 2003; 55: 403-409.
https://doi.org/10.1016/S0022-3999(03)00514-2 DOI: https://doi.org/10.1016/S0022-3999(03)00514-2
Donovan KA, Grassi L, McGinty HL, Jacobsen PB. Validation of the distress thermometer worldwide: state of the science. Psychooncology 2014; 23: 241-250.
https://doi.org/10.1002/pon.3430 DOI: https://doi.org/10.1002/pon.3430
Cutillo A, O'Hea E, Person S, Lessard D, Harralson T, Boudreaux E. The distress thermometer: cutoff points and clinical use. Oncol Nurs Forum 2017; 44: 329-336.
https://doi.org/10.1188/17.ONF.329-336 DOI: https://doi.org/10.1188/17.ONF.329-336
Prinsen CA, Lindeboom R, de Korte J. Interpretation of Skindex-29 scores: cutoffs for mild, moderate, and severe impairment of health-related quality of life. J Invest Dermatol 2011; 131: 1945-1947.
https://doi.org/10.1038/jid.2011.138 DOI: https://doi.org/10.1038/jid.2011.138
Zigmond AS, Snaith RP. The Hospital Anxiety and Depression scale. Acta Psychiatr Scand 1983; 67: 361-370.
https://doi.org/10.1111/j.1600-0447.1983.tb09716.x DOI: https://doi.org/10.1111/j.1600-0447.1983.tb09716.x
Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210-216.
https://doi.org/10.1111/j.1365-2230.1994.tb01167.x DOI: https://doi.org/10.1111/j.1365-2230.1994.tb01167.x
De Korte J, Mombers FM, Sprangers MA, Bos JD. The suitability of quality-of-life questionnaires for psoriasis research: a systematic literature review. Arch Dermatol 2002; 138: 1221-1227; discussion 1227.
https://doi.org/10.1001/archderm.138.9.1221 DOI: https://doi.org/10.1001/archderm.138.9.1221
Both H, Essink-Bot ML, Busschbach J, Nijsten T. Critical review of generic and dermatology-specific health-related quality of life instruments. J Invest Dermatol 2007; 127: 2726-2739.
https://doi.org/10.1038/sj.jid.5701142 DOI: https://doi.org/10.1038/sj.jid.5701142
Ma X, Zhang J, Zhong W, Shu C, Wang F, Wen J, et al. The diagnostic role of a short screening tool - the distress thermometer: a meta-analysis. Support Care Cancer 2014; 22: 1741-1755.
https://doi.org/10.1007/s00520-014-2143-1 DOI: https://doi.org/10.1007/s00520-014-2143-1
Klingenstein A, Samel C, Garip-Kuebler A, Miller C, Liegl RG, Priglinger SG, et al. The national comprehensive cancer network distress thermometer as a screening tool for the evaluation of quality of life in uveal melanoma patients. Acta Ophthalmol 2019; 10.1111/aos.14277.
https://doi.org/10.1111/aos.14277 DOI: https://doi.org/10.1111/aos.14277
Andreu Vaillo Y, Martinez Lopez P, Galdon Garrido MJ. Use of the distress thermometer in cancer survivors: convergent validity and diagnostic accuracy in a spanish sample. Oncol Nurs Forum 2019; 46: 442-450.
Lim HA, Mahendran R, Chua J, Peh CX, Lim SE, Kua EH. The Distress Thermometer as an ultra-short screening tool: a first validation study for mixed-cancer outpatients in Singapore. Compr Psychiatry 2014; 55: 1055-1062.
https://doi.org/10.1016/j.comppsych.2014.01.008 DOI: https://doi.org/10.1016/j.comppsych.2014.01.008
Verhoeven EW, Kraaimaat FW, van Weel C, van de Kerkhof PC, Duller P, van der Valk PG, et al. Skin diseases in family medicine: prevalence and health care use. Ann Fam Med 2008; 6: 349-354.
https://doi.org/10.1370/afm.861 DOI: https://doi.org/10.1370/afm.861
San Giorgi MR, Aaltonen LM, Rihkanen H, Tjon Pian Gi RE, van der Laan BF, Hoekstra-Weebers JE, et al. Validation of the distress thermometer and problem list in patients with recurrent respiratory papillomatosis. Otolaryngol Head Neck Surg 2017; 156: 180-188.
https://doi.org/10.1177/0194599816668307 DOI: https://doi.org/10.1177/0194599816668307
Chambers SK, Zajdlewicz L, Youlden DR, Holland JC, Dunn J. The validity of the distress thermometer in prostate cancer populations. Psychooncology 2014; 23: 195-203.
https://doi.org/10.1002/pon.3391 DOI: https://doi.org/10.1002/pon.3391
van Cranenburgh OD, Smets EM, de Rie MA, Sprangers MA, de Korte J. A Web-based, educational, quality-of-life intervention for patients with a chronic skin disease: feasibility and acceptance in routine dermatological practice. Acta Derm Venereol 2015; 95: 51-56.
https://doi.org/10.2340/00015555-1872 DOI: https://doi.org/10.2340/00015555-1872
Lavda AC, Webb TL, Thompson AR. A meta-analysis of the effectiveness of psychological interventions for adults with skin conditions. Br J Dermatol 2012; 167: 970-979.
https://doi.org/10.1111/j.1365-2133.2012.11183.x DOI: https://doi.org/10.1111/j.1365-2133.2012.11183.x
Finlay AY, Salek MS, Abeni D, Tomas-Aragones L, van Cranenburgh OD, Evers AW, et al. Why quality of life measurement is important in dermatology clinical practice: an expert-based opinion statement by the EADV Task Force on Quality of Life. J Eur Acad Dermatol Venereol 2017; 31: 424-431.
https://doi.org/10.1111/jdv.13985 DOI: https://doi.org/10.1111/jdv.13985
Velikova G, Awad N, Coles-Gale R, Wright EP, Brown JM, Selby PJ. The clinical value of quality of life assessment in oncology practice-a qualitative study of patient and physician views. Psychooncology 2008; 17: 690-698.
https://doi.org/10.1002/pon.1295 DOI: https://doi.org/10.1002/pon.1295
Detmar SB, Muller MJ, Schornagel JH, Wever LDV, Aaronson NK. Health-related quality-of-life assessments and patient-physician communication: a randomized controlled trial. JAMA 2002; 288: 3027-3034.
https://doi.org/10.1001/jama.288.23.3027 DOI: https://doi.org/10.1001/jama.288.23.3027
Hubbard JM, Grothey AF, McWilliams RR, Buckner JC, Sloan JA. Physician perspective on incorporation of oncology patient quality-of-life, fatigue, and pain assessment into clinical practice. J Oncol Pract 2014; 10: 248-253.
https://doi.org/10.1200/JOP.2013.001276 DOI: https://doi.org/10.1200/JOP.2013.001276
Published
How to Cite
License
Copyright (c) 2023 Tirza Blom, Karin B. Fieten, Patrick M.J.H. Kemperman, Saskia Spillekom-van Koulil, Rieky E.G. Dikmans
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
